Connect with us

Technology

Cashing in: Study shows banks investing big in GenAI, and it’s paying off

Published

on

Banking tops other industries in adopting the technology for marketing, risk management, customer service and more

CARY, N.C., Oct. 28, 2024 /PRNewswire/ — A new report on the use of generative AI in banking finds that financial services leads other industries in implementing the technology. A recent survey found that 17% of banking leaders have fully integrated GenAI into their regular processes. Further, 3 in 5 currently use GenAI to some degree – and nearly all the rest plan to begin soon. Obstacles remain, led by data privacy and security concerns. But the study confirmed that banks are already realizing GenAI gains across the business.

How does banking stack up to other sectors in the use and adoption of GenAI? Dive in at SAS.com/genai-banking.

The report, Your journey to a GenAI future: A strategic path to success in banking, is based on findings from a global, cross-industry survey by data and AI leader SAS and Coleman Parkes Research. Among 1,600 business leaders surveyed in 20 countries, 243 were senior banking execs who are decision makers on their organization’s GenAI strategy. Their insights offer an insider’s look at how banks are implementing GenAI, their biggest challenges, and how banking compares to industries like insurance, the public sector, health care, manufacturing, retail and more.

“GenAI is obviously a major trend across sectors right now, but maybe most significantly in financial services,” said Alex Kwiatkowski, Director of Global Financial Services at SAS. “Our survey found that banks, along with insurers, are currently using GenAI at higher rates than other industries. Among the many benefits early adopters are seeing, one of the most oft-cited by banking leaders is in risk management and compliance, where nearly nine in 10 reported improvements after deploying GenAI.”

Banks are all in on AI, with the budgets to prove it
The interest rates on savings accounts and loan applications may be ticking downward, but banks’ interest in generative AI is as high as ever. In fact, it’s nearly unanimous, with 98% of banking respondents either already using GenAI (60%, tied with insurance for the highest adoption rate) or planning to do so within the next two years (38%). And it’s not just talk: 90% said they have a dedicated GenAI budget for the coming year.

Beyond the 17% of banking leaders who reported fully implementing GenAI into their business processes, another 43% indicated they are experimenting with the technology at the enterprise level. Six in 10 said they have deployed at least one GenAI use case to date – the highest of any industry.

Banks are also using GenAI across departments and business functions. Compared with cross-industry averages, banks use GenAI at a higher rate in marketing (47%), IT (39%), sales (36%), finance (35%) and customer service (24%).

“GenAI technology is a double-edged sword for banks, as it has been weaponized by criminals to commit fraud faster than banks can adopt GenAI to protect their customers,” said Stu Bradley, Senior Vice President of Risk, Fraud and Compliance Solutions at SAS. “But better anti-fraud safeguards are just one of many potential advantages awaiting firms that take the GenAI leap. In fact, leaders on the first wave of GenAI implementation are seeing early returns on their investments in many areas of the bank.”

GenAI is already paying dividends in banking
The benefits from GenAI in banking aren’t just aspirational; they’re already happening, particularly in banks’ internal processes. Among bank leaders that have integrated GenAI, huge majorities are seeing gains in:

Employee experience and satisfaction (90%).Risk management and compliance (88%).Time savings and reduced operational costs (85%).

In addition, more than three-quarters reported improvements in customer satisfaction and retention (82%); efficiency in processing large data sets (78%); and sales or market share from data-driven insights (76%).

Marketing emerged as the most common area for banks to use GenAI, cited by 47% of banking leaders polled. A related SAS study, based on a separate survey of marketing professionals, found that banking marketers most frequently use GenAI for customer interactions (44%) and generating written copy (33%). They also plan to expand its use within the next year to audience targeting (64%) and trend analysis (64%).

Banking, like other industries, faces obstacles to GenAI success
Like many investments, GenAI does involve a degree of risk and uncertainty. Banking leaders’ foremost concerns involve protecting the privacy (74%) and security (71%) of their – and their customers’ – data. One potential solution? Synthetic data. Nearly one-third (29%) is already using this form of GenAI, and another 33% said they are actively considering it.

Implementation challenges are another obstacle facing the banking industry. Over half (54%) said that using public and proprietary data sets has been, or likely will be, an obstacle to implementing GenAI. And nearly as many (49%) said they are experiencing challenges moving GenAI from conceptual to practical.

Finally, banking leaders also worry about GenAI governance and regulation. Only 6% of those surveyed said their current governance framework is “well-established.” Most (58%) indicated that their frameworks are “in development” – but more than a third viewed theirs as either “ad hoc or informal” (27%) or “non-existent” (9%). The biggest hurdles to implementing effective governance and monitoring? Almost one-third (30%) cited technological limitations. Another 30% pointed to lack of transparency and accountability, a number that’s slightly higher than other industries.

“GenAI is changing the world of banking in ways that were previously unimaginable – and at astonishing speed,” said Kwiatkowski. “There is no shortcutting AI governance in banking or any industry. Trustworthy AI requires a foundation of human centricity, and it must embody the other core tenets of responsible innovation – inclusivity, transparency and accountability among them.”

Dig deeper into GenAI insights, in-person or online
Today’s announcement was made during Money20/20, branded the largest global fintech event enabling payments and finserv innovation, convening in Las Vegas, Oct. 27 – 30. Attendees are invited to engage with SAS experts on GenAI and other topics throughout the conference at Booth 3703.

To explore additional findings from SAS’ global GenAI study, download the banking report at SAS.com/genai-banking and check out SAS’ interactive GenAI data dashboard.

About SAS
SAS is a global leader in data and AI. With SAS software and industry-specific solutions, organizations transform data into trusted decisions. SAS gives you THE POWER TO KNOW®.

SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies. Copyright © 2024 SAS Institute Inc. All rights reserved.

Editorial Contact:         

Trey Whittenton             

Danielle Bates

Trey.Whittenton@sas.com   

Danielle.Bates@sas.com 

919-531-6829           

919-531-1959

sas.com/news

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cashing-in-study-shows-banks-investing-big-in-genai-and-its-paying-off-302288748.html

SOURCE SAS

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Waystar Announces Amendment to Its Credit Facilities

Published

on

By

Enhancements expected to boost flexibility and lower borrowing costs

LEHI, Utah and LOUISVILLE, Ky., Dec. 30, 2024 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced an amendment to its first lien credit agreement (the “amended credit agreement”) with its lenders. The amendment reprices Waystar’s term loan and increases its revolving credit facility.

Under the amended agreement, the term loan will now carry a reduced interest rate of adjusted SOFR +2.25%, down from the previous interest rate of adjusted SOFR +2.75%. In addition, Waystar will increase its revolving credit facility borrowing capacity to $400 million, up from $342.5 million, and lower the interest rate to adjusted SOFR +1.75%, compared to the previous interest rate of adjusted SOFR +2.25%. These changes are expected to reduce borrowing costs and generate interest expense savings for the company.

The amendments follow Waystar’s successful initial public offering on June 7, 2024, with net proceeds used to reduce debt, as well as an earlier loan repricing on June 27, 2024.

Additional details about the amended credit agreement are available in Waystar’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 30, 2024. The filing is available on the investor relations page of Waystar’s website at investors.waystar.com.

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, future borrowing costs, interest expense savings, and the impact of the amended credit agreement. Forward-looking statements include all statements that are not historical facts. These statements may include words such as “believe,” “could,” “expect,” “may,” “potential,” “predict,” “project,” “future,” “will,” the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release.

The forward-looking statements contained in this press release are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our ability to successfully execute on our business strategies in order to grow; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of “Risk Factors” in the Company’s prospectus filed with the Securities and Exchange Commission (the “SEC”) on June 7, 2024 and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

About Waystar
Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals Honor Roll. Waystar’s enterprise-grade platform annually processes over 5 billion healthcare payment transactions, including over $1.2 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Investor Contact
Sandy Draper
investors@waystar.com

Media Contact
Kristin Lee
kristin.lee@waystar.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-announces-amendment-to-its-credit-facilities-302340397.html

SOURCE Waystar

Continue Reading

Technology

SWEP Opens Large Scale Propane Testing Facility

Published

on

By

DOWNERS GROVE, Ill., Dec. 30, 2024 /PRNewswire/ — SWEP, part of Dover (NYSE: DOV) and a world-leading supplier of brazed plate heat exchangers (BPHEs), today announced the opening of a new rig for propane testing at the SWEP Research & Development Center in Landskrona, Sweden.

Recent policies such as the European F-Gas Regulation are driving market demand for heating and cooling systems that operate with natural- or low-GWP refrigerants. The capability to run large scale propane testing is an important step for SWEP to meet current and future need for sustainable heat transfer solutions. The heating and cooling sector (HVAC) accounts for a significant share of global energy consumption, and the industry is challenged to find innovations to accelerate decarbonization.

“The new test rig will be crucial in the development of brazed plate heat exchangers that are optimized for systems based on natural refrigerants. We are working closely with our customers to create products that meet system design requirements of next-generation heat pumps and chillers,” says Ulrika Nordqvist, SWEP President.

SWEP has been able to test small- and medium-sized units with propane since 2019, and the new rig will now enable in-house testing of up to XL-size units.

“The new test rig is optimized for a wide propane envelope and will be instrumental in the ongoing development of highly efficient and safe heat transfer solutions. We will continue to support our customers in the transition towards more sustainable heating and cooling systems,” says Fabienne Bourquenoud Moret, VP of Marketing, Research & Development at SWEP.

Although propane gas has a low GWP, its flammable properties make it hazardous to handle in a test environment. Ensuring operational safety and quality has been central in the launch of the new rig, which is part of SWEP’s Global Investment Program. Running from 2019 through 2025, the program seeks to strengthen SWEP’s long-term capacity and add new capabilities to help ensure customer success and accelerate growth.

About SWEP:
At SWEP, we believe our future rests on giving more energy than we take – from our planet and our people. That’s why we pour our energy into leading the conversion to sustainable energy usage in heat transfer. Over three decades, the SWEP brand has become synonymous with challenging efficiency.

SWEP is a world-leading supplier of brazed plate heat exchangers for HVAC and industrial applications. With over 1,100 dedicated employees, carefully selected business partners, and a global presence with production, sales, and dedicated service, we bring a level of expertise and closeness to our customers that’s redefining competitive edge in a more sustainable future. SWEP is part of Dover Corporation, a multi-billion-dollar, diversified manufacturer of a wide range of proprietary products and components for industrial and commercial use.

About Dover:
Dover is a diversified global manufacturer and solutions provider with annual revenue of over $7 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 65 years, our team of over 24,000 employees takes an ownership mindset, collaborating with customers to redefine what’s possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under “DOV.” Additional information is available at dovercorporation.com.   

SWEP Contact: 
Malin Bengtsson
+46 418 400 720
malin.bengtsson@swep.net 

Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com

Dover Investor Contact:
Jack Dickens, VP, Investor Relations
(630) 743-2566
jdickens@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/swep-opens-large-scale-propane-testing-facility-302340339.html

SOURCE Dover

Continue Reading

Technology

SIGMA LITHIUM EXCEEDS 4Q2024 TARGETS WITH 75,000T OF QUINTUPLE ZERO GREEN LITHIUM PRODUCED; POSITIONED TO SURPASS 270,000T IN 2025

Published

on

By

SÃO PAULO, Dec. 30, 2024 /PRNewswire/ — Sigma Lithium Corporation (TSXV/NASDAQ: SGML, BVMF: S2GM34) (“Sigma Lithium” or the “Company”), a leading global lithium producer dedicated to powering the next generation of electric vehicles with carbon-neutral, socially and environmentally sustainable lithium concentrate (“Quintuple Zero Green Lithium”), is pleased to announce the successful completion of the 2024 business year, significantly exceeding fourth-quarter production target with approximately 75,000 tonnes produced, and achieving a total of approximately 240,000 tonnes in production and sales volumes for the year. With its strong operational performance and commitment to sustainable growth, Sigma Lithium is well-positioned to exceed its 2025 production target of 270,000 tonnes.

Ana Cabral, CEO and Co-Chairman of Sigma Lithium, said, “With the successful completion of the fourth quarter, we are demonstrating mastery of our innovative green industrialization technologies for lithium processing and dense media separation. Our Greentech Industrial Plant is delivering lithium materials that are aligned with the ethos of the consumers of the electric vehicles, and this gives our team a tremendous sense of purpose and accomplishment. Exceeding production and commercial targets in the fourth quarter has reinforced our confidence in our ability to surpass our 2025 production targets. This remarkable year is a testament to the relentless pursuit of excellence by a highly dedicated team, showing that innovation thrives in diverse work environments”.

She added: “We are also deeply honored by the embrace and support we have received throughout this year from all of our stakeholders: our neighbors at Vale do Jequitinhonha, our Federal Government of Brazil, our State Government of Minas Gerais, our customers, BNDES, our shareholders. Sigma Lithium’s accomplishments this year would not have been possible without you. In 2025, we are well-positioned to exceed expectations and bring continued growth and shared prosperity to our region”.

ABOUT SIGMA LITHIUM
Sigma Lithium (TSXV/NASDAQ: SGML, BVMF: S2GM34) is a leading global lithium producer dedicated to powering the next generation of electric vehicle batteries with carbon-neutral, socially and environmentally sustainable chemical-grade lithium concentrate.

Sigma Lithium is one of the world’s largest lithium producers. The Company operates at the forefront of environmental and social sustainability in the electric vehicle battery materials supply chain at its Grota do Cirilo Operation in Brazil. Here, Sigma produces Quintuple Zero Green Lithium at its state-of-the-art Greentech lithium beneficiation plant, delivering net zero carbon lithium, produced with zero carbon intensive energy, zero potable water, zero toxic chemicals and zero tailings dams.

Phase 1 of the Company’s operations entered commercial production in the second quarter of 2023. The Company has issued a Final Investment Decision, formally approving construction to double capacity to 520,000 tonnes of lithium concentrate through the addition of a Phase 2 expansion of its Greentech Plant.

For more information about Sigma Lithium, visit https://www.sigmalithiumresources.com/

Sigma Lithium
LinkedIn: Sigma Lithium
Instagram: @sigmalithium
X (Twitter): @SigmaLithium

FORWARD-LOOKING STATEMENTS

This news release includes certain “forward-looking information” under applicable Canadian and U.S. securities legislation, including but not limited to statements relating to timing and costs related to the general business and operational outlook of the Company, the environmental footprint of tailings and positive ecosystem impact relating thereto, donation and upcycling of tailings, timing and quantities relating to tailings and Green Lithium, achievements and projections relating to the Zero Tailings strategy, achievement of ramp-up volumes, production estimates and the operational status of the Groto do Cirilo Project, and other forward-looking information. All statements that address future plans, activities, events, estimates, expectations or developments that the Company believes, expects or anticipates will or may occur is forward-looking information, including statements regarding the potential development of mineral resources and mineral reserves which may or may not occur. Forward-looking information contained herein is based on certain assumptions regarding, among other things: general economic and political conditions; the stable and supportive legislative, regulatory and community environment in Brazil; demand for lithium, including that such demand is supported by growth in the electric vehicle market; the Company’s market position and future financial and operating performance; the Company’s estimates of mineral resources and mineral reserves, including whether mineral resources will ever be developed into mineral reserves; and the Company’s ability to operate its mineral projects including that the Company will not experience any materials or equipment shortages, any labour or service provider outages or delays or any technical issues. Although management believes that the assumptions and expectations reflected in the forward-looking information are reasonable, there can be no assurance that these assumptions and expectations will prove to be correct. Forward-looking information inherently involves and is subject to risks and uncertainties, including but not limited to that the market prices for lithium may not remain at current levels; and the market for electric vehicles and other large format batteries currently has limited market share and no assurances can be given for the rate at which this market will develop, if at all, which could affect the success of the Company and its ability to develop lithium operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, except as required by law. For more information on the risks, uncertainties and assumptions that could cause our actual results to differ from current expectations, please refer to the current annual information form of the Company and other public filings available under the Company’s profile at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sigma-lithium-exceeds-4q2024-targets-with-75-000t-of-quintuple-zero-green-lithium-produced-positioned-to-surpass-270-000t-in-2025–302340413.html

SOURCE Sigma Lithium Corporation

Continue Reading

Trending